跳至主要内容
临床试验/NCT00829699
NCT00829699已完成早期 1 期

Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus, Question 3

University of Maryland, Baltimore2 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2009年7月最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
状态
已完成
入组人数
31
试验地点
2
主要终点
Percent change in flow mediated dilation of brachial artery

研究概览

简要总结

The purpose of this study is to learn more about why patients with diabetes have increased heart attacks, strokes and other illnesses due to blood clots causing blockage of a blood vessel. The proposed protocol will study the separate and combined effects of high glucose and high fats on certain cardiovascular responses in Type 2 DM.

详细描述

Currently 75-80% of diabetes mellitus (DM) patients die due to thrombotic causes. Data from the Centers for Disease Control and Prevention released in 2000 indicated that mortality due to coronary artery disease is decreasing except in individuals with diabetes. Clearly the disordered metabolism, which includes abnormal metabolism of fats resulting in higher triglyceride and free fatty acid blood levels, occurring in diabetes predisposes these individuals to increased thrombotic events. Unless the underlying mechanisms responsible for these events can be identified, there will be an unprecedented number of diabetic patients suffering thrombotic episodes in the next 10 years.

The specific aims of this study are to determine the effects of elevated free fatty acids and hyperglycemia (high glucose)on endothelial function and thrombolytic balance in patients with type 2 diabetes, and to determine the effects of increased insulin in this setting.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

1

Experimental

Euinsulinemic (low insulin infusion) Euglycemic (normal blood glucose levels) glucose clamp with lipid (fat) infusion

干预措施: euinsulinemic euglycemic glucose clamp (Procedure)

2

Experimental

Euinsulinemic Hyperglycemic (high glucose levels) glucose clamp with lipid infusion

干预措施: euinsulinemic hyperglycemic glucose clamp (Procedure)

3

Experimental

Hyperinsulinemic (High dose insulin) euglycemic glucose clamp with lipid infusion

干预措施: Hyperinsulinemic euglycemic glucose clamp (Procedure)

4

Experimental

Hyperinsulinemic hyperglycemic (high glucose level) glucose clamp with lipid infusion

干预措施: Hyperinsulinemic hyperglycemic glucose clamp (Procedure)

结局指标

主要结局

Percent change in flow mediated dilation of brachial artery

时间窗: 4 hours

次要结局

  • Change in Lipid measures(4hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephen N. Davis, MBBS

Professor

University of Maryland, Baltimore

研究点 (2)

Loading locations...

相似试验